Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells

As previously shown, constitutive activation of the small GTPase Rho and its downstream target Rho-kinase is crucial for spontaneous migration of Walker carcinosarcoma cells. We now show that after treatment of cells with either the Rho inhibitor C3 exoenzyme or the Rho-kinase inhibitor Y-27632, con...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental cell research 2005-08, Vol.308 (2), p.422-438
Hauptverfasser: Gutjahr, Marc C., Rossy, Jérémie, Niggli, Verena
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 438
container_issue 2
container_start_page 422
container_title Experimental cell research
container_volume 308
creator Gutjahr, Marc C.
Rossy, Jérémie
Niggli, Verena
description As previously shown, constitutive activation of the small GTPase Rho and its downstream target Rho-kinase is crucial for spontaneous migration of Walker carcinosarcoma cells. We now show that after treatment of cells with either the Rho inhibitor C3 exoenzyme or the Rho-kinase inhibitor Y-27632, constitutive myosin light chain (MLC) phosphorylation is significantly decreased, correlating with inhibition of cell polarization and migration. Transfection with a dominant-negative Rho-kinase mutant similarly inhibits cell polarization and MLC phosphorylation. Transfection with a dominant-active Rho-kinase mutant leads to significantly increased MLC phosphorylation, membrane blebbing, and inhibition of cell polarization. This Rho-kinase-induced membrane blebbing can be inhibited by Y-27632, ML-7, and blebbistatin. Unexpectedly, overactivation of RhoA has similar effects as its inhibition. Introduction of a bacterially expressed constitutively activated mutant protein (but not of wild-type RhoA) into the cells or transfection of cells with a constitutively active RhoA mutant both inhibit polarization and decrease MLC phosphorylation. Transfection of cells with constitutively active or dominant-negative Rac both abrogate polarity, and the latter inhibits MLC phosphorylation. Our findings suggest an important role of Rac, Rho/Rho-kinase, and MLCK in controlling myosin activity in Walker carcinosarcoma cells and show that an appropriate level of RhoA, Rac, and Rho-kinase activity is required to regulate cell polarity and migration.
doi_str_mv 10.1016/j.yexcr.2005.05.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68428444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014482705002156</els_id><sourcerecordid>68428444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-a011d1dfa5f2cdcab5ff83c0fdb3e330f5a2d5291f985aefb66ca68618d9b2ef3</originalsourceid><addsrcrecordid>eNp9kd-K1DAUxoMo7rj6BIIEL7yajknaZNMLL2TxHywIg-JlSJOTncy2SU06i30bH9XUDgpeCCcckvzOl498CD2nZEcJFa-Puxl-mLRjhPDdUoQ-QBtKWlKxhrGHaFNOmqqR7OoCPcn5SAiRkorH6ILylpNWiA36uY894Ojw_hC3eK_NFutgl11154POgH3A4yHmstLc68nHsODDHHO56f3tYcLmoH3YYgv30MdxgDAtyBh7nfw0r4p5jGHSAeIp48Hfpj9K33R_BwkzLrDRyfgQc2lx0NhA3-en6JHTfYZn536Jvr5_9-X6Y3Xz-cOn67c3lWk4mSpNKLXUOs0dM9bojjsna0Oc7Wqoa-K4ZpazlrpWcg2uE8JoIQWVtu0YuPoSvVp1xxS_nyBPavB5cbB6VkI2TDZNU8CX_4DHeEqheFO0bcQVJZIXqF4hk2LOCZwakx90mhUlaklPHdXv9NSSnlqK0DL14ix96gawf2fOcRXgzQpA-Yl7D0ll4yEYsD6BmZSN_r8P_AKwua9R</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>194671085</pqid></control><display><type>article</type><title>Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gutjahr, Marc C. ; Rossy, Jérémie ; Niggli, Verena</creator><creatorcontrib>Gutjahr, Marc C. ; Rossy, Jérémie ; Niggli, Verena</creatorcontrib><description>As previously shown, constitutive activation of the small GTPase Rho and its downstream target Rho-kinase is crucial for spontaneous migration of Walker carcinosarcoma cells. We now show that after treatment of cells with either the Rho inhibitor C3 exoenzyme or the Rho-kinase inhibitor Y-27632, constitutive myosin light chain (MLC) phosphorylation is significantly decreased, correlating with inhibition of cell polarization and migration. Transfection with a dominant-negative Rho-kinase mutant similarly inhibits cell polarization and MLC phosphorylation. Transfection with a dominant-active Rho-kinase mutant leads to significantly increased MLC phosphorylation, membrane blebbing, and inhibition of cell polarization. This Rho-kinase-induced membrane blebbing can be inhibited by Y-27632, ML-7, and blebbistatin. Unexpectedly, overactivation of RhoA has similar effects as its inhibition. Introduction of a bacterially expressed constitutively activated mutant protein (but not of wild-type RhoA) into the cells or transfection of cells with a constitutively active RhoA mutant both inhibit polarization and decrease MLC phosphorylation. Transfection of cells with constitutively active or dominant-negative Rac both abrogate polarity, and the latter inhibits MLC phosphorylation. Our findings suggest an important role of Rac, Rho/Rho-kinase, and MLCK in controlling myosin activity in Walker carcinosarcoma cells and show that an appropriate level of RhoA, Rac, and Rho-kinase activity is required to regulate cell polarity and migration.</description><identifier>ISSN: 0014-4827</identifier><identifier>EISSN: 1090-2422</identifier><identifier>DOI: 10.1016/j.yexcr.2005.05.001</identifier><identifier>PMID: 15950966</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Carcinoma 256, Walker - metabolism ; Cell Line, Tumor ; Cell migration ; Cell Movement - physiology ; Cell Polarity - physiology ; Cell Surface Extensions - enzymology ; Down-Regulation - drug effects ; Down-Regulation - physiology ; Enzyme Inhibitors - pharmacology ; Intracellular Signaling Peptides and Proteins ; Membrane blebbing ; Mutation - physiology ; Myosin light chain ; Myosin light chain kinase ; Myosin Light Chains - metabolism ; Myosin Type II - metabolism ; Neoplasm Invasiveness - physiopathology ; Neoplasm Metastasis - physiopathology ; Phosphorylation - drug effects ; Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors ; Protein-Serine-Threonine Kinases - genetics ; Protein-Serine-Threonine Kinases - metabolism ; Rac ; rac GTP-Binding Proteins - antagonists &amp; inhibitors ; rac GTP-Binding Proteins - genetics ; rac GTP-Binding Proteins - metabolism ; Rho ; rho GTP-Binding Proteins - antagonists &amp; inhibitors ; rho GTP-Binding Proteins - genetics ; rho GTP-Binding Proteins - metabolism ; rho-Associated Kinases ; Rho-kinase ; Transfection ; Walker carcinosarcoma cell</subject><ispartof>Experimental cell research, 2005-08, Vol.308 (2), p.422-438</ispartof><rights>2005 Elsevier Inc.</rights><rights>Copyright © 2005 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-a011d1dfa5f2cdcab5ff83c0fdb3e330f5a2d5291f985aefb66ca68618d9b2ef3</citedby><cites>FETCH-LOGICAL-c450t-a011d1dfa5f2cdcab5ff83c0fdb3e330f5a2d5291f985aefb66ca68618d9b2ef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.yexcr.2005.05.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15950966$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gutjahr, Marc C.</creatorcontrib><creatorcontrib>Rossy, Jérémie</creatorcontrib><creatorcontrib>Niggli, Verena</creatorcontrib><title>Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells</title><title>Experimental cell research</title><addtitle>Exp Cell Res</addtitle><description>As previously shown, constitutive activation of the small GTPase Rho and its downstream target Rho-kinase is crucial for spontaneous migration of Walker carcinosarcoma cells. We now show that after treatment of cells with either the Rho inhibitor C3 exoenzyme or the Rho-kinase inhibitor Y-27632, constitutive myosin light chain (MLC) phosphorylation is significantly decreased, correlating with inhibition of cell polarization and migration. Transfection with a dominant-negative Rho-kinase mutant similarly inhibits cell polarization and MLC phosphorylation. Transfection with a dominant-active Rho-kinase mutant leads to significantly increased MLC phosphorylation, membrane blebbing, and inhibition of cell polarization. This Rho-kinase-induced membrane blebbing can be inhibited by Y-27632, ML-7, and blebbistatin. Unexpectedly, overactivation of RhoA has similar effects as its inhibition. Introduction of a bacterially expressed constitutively activated mutant protein (but not of wild-type RhoA) into the cells or transfection of cells with a constitutively active RhoA mutant both inhibit polarization and decrease MLC phosphorylation. Transfection of cells with constitutively active or dominant-negative Rac both abrogate polarity, and the latter inhibits MLC phosphorylation. Our findings suggest an important role of Rac, Rho/Rho-kinase, and MLCK in controlling myosin activity in Walker carcinosarcoma cells and show that an appropriate level of RhoA, Rac, and Rho-kinase activity is required to regulate cell polarity and migration.</description><subject>Animals</subject><subject>Carcinoma 256, Walker - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell migration</subject><subject>Cell Movement - physiology</subject><subject>Cell Polarity - physiology</subject><subject>Cell Surface Extensions - enzymology</subject><subject>Down-Regulation - drug effects</subject><subject>Down-Regulation - physiology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>Membrane blebbing</subject><subject>Mutation - physiology</subject><subject>Myosin light chain</subject><subject>Myosin light chain kinase</subject><subject>Myosin Light Chains - metabolism</subject><subject>Myosin Type II - metabolism</subject><subject>Neoplasm Invasiveness - physiopathology</subject><subject>Neoplasm Metastasis - physiopathology</subject><subject>Phosphorylation - drug effects</subject><subject>Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors</subject><subject>Protein-Serine-Threonine Kinases - genetics</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Rac</subject><subject>rac GTP-Binding Proteins - antagonists &amp; inhibitors</subject><subject>rac GTP-Binding Proteins - genetics</subject><subject>rac GTP-Binding Proteins - metabolism</subject><subject>Rho</subject><subject>rho GTP-Binding Proteins - antagonists &amp; inhibitors</subject><subject>rho GTP-Binding Proteins - genetics</subject><subject>rho GTP-Binding Proteins - metabolism</subject><subject>rho-Associated Kinases</subject><subject>Rho-kinase</subject><subject>Transfection</subject><subject>Walker carcinosarcoma cell</subject><issn>0014-4827</issn><issn>1090-2422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kd-K1DAUxoMo7rj6BIIEL7yajknaZNMLL2TxHywIg-JlSJOTncy2SU06i30bH9XUDgpeCCcckvzOl498CD2nZEcJFa-Puxl-mLRjhPDdUoQ-QBtKWlKxhrGHaFNOmqqR7OoCPcn5SAiRkorH6ILylpNWiA36uY894Ojw_hC3eK_NFutgl11154POgH3A4yHmstLc68nHsODDHHO56f3tYcLmoH3YYgv30MdxgDAtyBh7nfw0r4p5jGHSAeIp48Hfpj9K33R_BwkzLrDRyfgQc2lx0NhA3-en6JHTfYZn536Jvr5_9-X6Y3Xz-cOn67c3lWk4mSpNKLXUOs0dM9bojjsna0Oc7Wqoa-K4ZpazlrpWcg2uE8JoIQWVtu0YuPoSvVp1xxS_nyBPavB5cbB6VkI2TDZNU8CX_4DHeEqheFO0bcQVJZIXqF4hk2LOCZwakx90mhUlaklPHdXv9NSSnlqK0DL14ix96gawf2fOcRXgzQpA-Yl7D0ll4yEYsD6BmZSN_r8P_AKwua9R</recordid><startdate>20050815</startdate><enddate>20050815</enddate><creator>Gutjahr, Marc C.</creator><creator>Rossy, Jérémie</creator><creator>Niggli, Verena</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20050815</creationdate><title>Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells</title><author>Gutjahr, Marc C. ; Rossy, Jérémie ; Niggli, Verena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-a011d1dfa5f2cdcab5ff83c0fdb3e330f5a2d5291f985aefb66ca68618d9b2ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Carcinoma 256, Walker - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell migration</topic><topic>Cell Movement - physiology</topic><topic>Cell Polarity - physiology</topic><topic>Cell Surface Extensions - enzymology</topic><topic>Down-Regulation - drug effects</topic><topic>Down-Regulation - physiology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>Membrane blebbing</topic><topic>Mutation - physiology</topic><topic>Myosin light chain</topic><topic>Myosin light chain kinase</topic><topic>Myosin Light Chains - metabolism</topic><topic>Myosin Type II - metabolism</topic><topic>Neoplasm Invasiveness - physiopathology</topic><topic>Neoplasm Metastasis - physiopathology</topic><topic>Phosphorylation - drug effects</topic><topic>Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors</topic><topic>Protein-Serine-Threonine Kinases - genetics</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Rac</topic><topic>rac GTP-Binding Proteins - antagonists &amp; inhibitors</topic><topic>rac GTP-Binding Proteins - genetics</topic><topic>rac GTP-Binding Proteins - metabolism</topic><topic>Rho</topic><topic>rho GTP-Binding Proteins - antagonists &amp; inhibitors</topic><topic>rho GTP-Binding Proteins - genetics</topic><topic>rho GTP-Binding Proteins - metabolism</topic><topic>rho-Associated Kinases</topic><topic>Rho-kinase</topic><topic>Transfection</topic><topic>Walker carcinosarcoma cell</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gutjahr, Marc C.</creatorcontrib><creatorcontrib>Rossy, Jérémie</creatorcontrib><creatorcontrib>Niggli, Verena</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental cell research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gutjahr, Marc C.</au><au>Rossy, Jérémie</au><au>Niggli, Verena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells</atitle><jtitle>Experimental cell research</jtitle><addtitle>Exp Cell Res</addtitle><date>2005-08-15</date><risdate>2005</risdate><volume>308</volume><issue>2</issue><spage>422</spage><epage>438</epage><pages>422-438</pages><issn>0014-4827</issn><eissn>1090-2422</eissn><abstract>As previously shown, constitutive activation of the small GTPase Rho and its downstream target Rho-kinase is crucial for spontaneous migration of Walker carcinosarcoma cells. We now show that after treatment of cells with either the Rho inhibitor C3 exoenzyme or the Rho-kinase inhibitor Y-27632, constitutive myosin light chain (MLC) phosphorylation is significantly decreased, correlating with inhibition of cell polarization and migration. Transfection with a dominant-negative Rho-kinase mutant similarly inhibits cell polarization and MLC phosphorylation. Transfection with a dominant-active Rho-kinase mutant leads to significantly increased MLC phosphorylation, membrane blebbing, and inhibition of cell polarization. This Rho-kinase-induced membrane blebbing can be inhibited by Y-27632, ML-7, and blebbistatin. Unexpectedly, overactivation of RhoA has similar effects as its inhibition. Introduction of a bacterially expressed constitutively activated mutant protein (but not of wild-type RhoA) into the cells or transfection of cells with a constitutively active RhoA mutant both inhibit polarization and decrease MLC phosphorylation. Transfection of cells with constitutively active or dominant-negative Rac both abrogate polarity, and the latter inhibits MLC phosphorylation. Our findings suggest an important role of Rac, Rho/Rho-kinase, and MLCK in controlling myosin activity in Walker carcinosarcoma cells and show that an appropriate level of RhoA, Rac, and Rho-kinase activity is required to regulate cell polarity and migration.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15950966</pmid><doi>10.1016/j.yexcr.2005.05.001</doi><tpages>17</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4827
ispartof Experimental cell research, 2005-08, Vol.308 (2), p.422-438
issn 0014-4827
1090-2422
language eng
recordid cdi_proquest_miscellaneous_68428444
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Carcinoma 256, Walker - metabolism
Cell Line, Tumor
Cell migration
Cell Movement - physiology
Cell Polarity - physiology
Cell Surface Extensions - enzymology
Down-Regulation - drug effects
Down-Regulation - physiology
Enzyme Inhibitors - pharmacology
Intracellular Signaling Peptides and Proteins
Membrane blebbing
Mutation - physiology
Myosin light chain
Myosin light chain kinase
Myosin Light Chains - metabolism
Myosin Type II - metabolism
Neoplasm Invasiveness - physiopathology
Neoplasm Metastasis - physiopathology
Phosphorylation - drug effects
Protein-Serine-Threonine Kinases - antagonists & inhibitors
Protein-Serine-Threonine Kinases - genetics
Protein-Serine-Threonine Kinases - metabolism
Rac
rac GTP-Binding Proteins - antagonists & inhibitors
rac GTP-Binding Proteins - genetics
rac GTP-Binding Proteins - metabolism
Rho
rho GTP-Binding Proteins - antagonists & inhibitors
rho GTP-Binding Proteins - genetics
rho GTP-Binding Proteins - metabolism
rho-Associated Kinases
Rho-kinase
Transfection
Walker carcinosarcoma cell
title Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T06%3A59%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Rho,%20Rac,%20and%20Rho-kinase%20in%20phosphorylation%20of%20myosin%20light%20chain,%20development%20of%20polarity,%20and%20spontaneous%20migration%20of%20Walker%20256%20carcinosarcoma%20cells&rft.jtitle=Experimental%20cell%20research&rft.au=Gutjahr,%20Marc%20C.&rft.date=2005-08-15&rft.volume=308&rft.issue=2&rft.spage=422&rft.epage=438&rft.pages=422-438&rft.issn=0014-4827&rft.eissn=1090-2422&rft_id=info:doi/10.1016/j.yexcr.2005.05.001&rft_dat=%3Cproquest_cross%3E68428444%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=194671085&rft_id=info:pmid/15950966&rft_els_id=S0014482705002156&rfr_iscdi=true